NCT06945341

Brief Summary

Focus-Group based discussion designed to gain more in-depth information on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 18, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

April 25, 2025

Completed
2 months until next milestone

Study Start

First participant enrolled

July 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

May 4, 2026

Status Verified

April 1, 2026

Enrollment Period

6 months

First QC Date

April 18, 2025

Last Update Submit

April 28, 2026

Conditions

AnesthesiaNeuromuscular BlockadeNeuromuscular Block, ResidualPerioperative/Postoperative ComplicationsAnaesthesiology Devices Associated With Adverse Incidents, Diagnostic and Monitoring Devices

Outcome Measures

Primary Outcomes (1)

  • Thematic analysis

    Thematic analysis of factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts

    90 minutes

Study Arms (4)

Group 1 Central and Eastern Europe

Central and Eastern Europe

Behavioral: Focus-Group discussion

Group 2 Northern Europe

Northern Europe

Behavioral: Focus-Group discussion

Group 3 Southern Europe

Southern Europe

Behavioral: Focus-Group discussion

Group 4 Western Europe

Western Europe

Behavioral: Focus-Group discussion

Interventions

Focus-Group discussionBEHAVIORAL

Focus-Group discussion on factors that could lead to an increase in the adoption of neuromuscular monitoring taking into account different country-specific contexts.

Group 1 Central and Eastern EuropeGroup 2 Northern EuropeGroup 3 Southern EuropeGroup 4 Western Europe

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Active EU Anaesthesiologists

Active EU Anaesthesiologists

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Study Sites (1)

AZ Sint Jan

Bruges, WV, 8000, Belgium

Location

MeSH Terms

Conditions

Delayed Emergence from AnesthesiaPostoperative ComplicationsDisease

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Consultant

Study Record Dates

First Submitted

April 18, 2025

First Posted

April 25, 2025

Study Start

July 1, 2025

Primary Completion

December 31, 2025

Study Completion

April 30, 2026

Last Updated

May 4, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Focus-Group thematic analysis

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE

Locations

BE(1)